Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the National Cancer Institute

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15292388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer

  2004cited by this paper
• betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.

  2003cited by this paper
• Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.

  2003cited by this paper
• Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene.

  2003cited by this paper
• beta-Catenin and ras oncogenes detect most human colorectal cancer.

  2003cited by this paper
• A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).

  2003cited by this paper
• Tumor formation by genetic mutations in the components of the Wnt signaling pathway

  2003cited by this paper
• Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.

  2003cited by this paper
• Emi1 proteolysis: how SCF(beta-Trcp1) helps to activate the anaphase-promoting complex.

  2003cited by this paper
• The role of ubiquitin-proteasome pathway in oncogenic signaling.

  2002cited by this paper
• APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers.

  2002cited by this paper
• Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling

  2002cited by this paper
• Beta-catenin--a linchpin in colorectal carcinogenesis?

  2002cited by this paper
• Inhibition of HOS expression and activities by Wnt pathway

  2002cited by this paper
• NF-kappaB at the crossroads of life and death.

  2002cited by this paper
• Ubiquitin‐mediated degradation of cellular proteins in health and disease

  2002cited by this paper
• Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC

  2002cited by this paper
• Emerging concepts in colorectal neoplasia.

  2002cited by this paper
• p53-Mdm2--the affair that never ends.

  2002cited by this paper
• Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100.

  2002cited by this paper
• Cancer Statistics, 2002

  2002cited by this paper
• Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.

  2002cited by this paper
• Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas

  2001cited by this paper
• The Hedgehog and Wnt signalling pathways in cancer

  2001cited by this paper
• Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB.

  2001cited by this paper
• Expression profiles of betaTRCP1 and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer.

  2001cited by this paper
• MDM2: life without p53.

  2001cited by this paper
• ATF4 Degradation Relies on a Phosphorylation-Dependent Interaction with the SCFβTrCPUbiquitin Ligase

  2001cited by this paper
• Blocking oncogenic Ras signaling for cancer therapy.

  2001cited by this paper
• Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

  2001cited by this paper
• Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines

  2001cited by this paper
• Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors

  2000cited by this paper
• NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases.

  2000cited by this paper
• Ubiquitin‐mediated proteolysis: biological regulation via destruction

  2000cited by this paper
• Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.

  2000cited by this paper
• The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

  2000cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.

  2000cited by this paper
• Basic Medical Research Award. The ubiquitin system.

  2000cited by this paper
• Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor.

  2000cited by this paper
• beta-catenin expression in primary and metastatic colorectal carcinoma.

  1999cited by this paper
• The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

  1999cited by this paper
• Inducible Degradation of IκBα by the Proteasome Requires Interaction with the F-box Protein h-βTrCP*

  1999cited by this paper
• Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

  1999cited by this paper
• Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.

  1999cited by this paper
• Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.

  1999cited by this paper
• The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

  1999cited by this paper
• Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis.

  1999cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

  1999cited by this paper
• beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation.

  1999cited by this paper
• Activators and target genes of Rel/NF-kappaB transcription factors.

  1999cited by this paper
• The oncogenic activation of beta-catenin.

  1999cited by this paper
• Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia

  1999cited by this paper
• A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways.

  1999cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

  1998cited by this paper
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997cited by this paper
• Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.

  1997cited by this paper
• p27 expression and gastric carcinoma

  1997cited by this paper
• beta-catenin is a target for the ubiquitin-proteasome pathway.

  1997cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.

  1997cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• IkappaB kinase: beginning, not the end.

  1997cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Simultaneous detection of TDT-mediated dUTP-biotin nick end-labeling (TUNEL)-positive cells and multiple immunohistochemical markers in single tissue sections.

  1995cited by this paper
• Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

  1995cited by this paper
• An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1990cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Targeting the ubiquitin–proteasome system and drug therapy in colorectal cancer

  2025cites this paper
• β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

  2025cites this paper
• MicroRNAs as the critical regulators of ubiquitin-proteasome system through F-box protein targeting during tumor progression

  2025cites this paper
• UPS and Kinases—Gatekeepers of the G1/S Transition

  2025cites this paper
• The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis

  2024cites this paper
• E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities.

  2024cites this paper
• A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure-activity relationship.

  2024cites this paper
• βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells.

  2023cites this paper
• The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

  2023cites this paper
• Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains

  2023cites this paper
• MYO10 regulates genome stability and cancer inflammation through mediating mitosis

  2023cites this paper
• Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer

  2023cites this paper
• Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Beta-Transducin Repeats-Containing Proteins as an Anticancer Target

  2023cites this paper
• Pellino 3 promotes the colitis‐associated colorectal cancer through suppression of IRF4‐mediated negative regulation of TLR4 signalling

  2023cites this paper
• The role of E3 ubiquitin ligases in bone homeostasis and related diseases

  2023cites this paper
• The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer

  2023cites this paper
• CRD-BP as a Tumor Marker of Colorectal Cancer.

  2023cites this paper
• Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration

  2022cites this paper
• Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor

  2022cites this paper
• Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

  2021cites this paper
• F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2

  2021cites this paper
• E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation

  2021cites this paper
• The SCF Complex Is Essential to Maintain Genome and Chromosome Stability

  2021cites this paper
• TRIMs: selective recruitment at different steps of the NF-κB pathway—determinant of activation or resolution of inflammation

  2021cites this paper
• Ubiquitin ligases in cancer: functions and clinical potentials.

  2021cites this paper
• Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy

  2021cites this paper
• Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer

  2021cites this paper
• lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer

  2020cites this paper
• Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins

  2020cites this paper
• F-Box Proteins and Cancer

  2020cites this paper
• β-TrCP suppresses the migration and invasion of trophoblast cells in preeclampsia by down-regulating Snail.

  2020cites this paper
• Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer.

  2020cites this paper
• The characteristics and roles of β‐TrCP1/2 in carcinogenesis

  2020cites this paper
• Regulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer

  2020cites this paper
• Ubiquitin-Regulated Cell Proliferation and Cancer.

  2020cites this paper
• MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.

  2020cites this paper
• Emerging roles of F-box proteins in cancer drug resistance.

  2019cites this paper
• Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs

  2019cites this paper
• FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway

  2019cites this paper
• COX-2 mediated crosstalk between Wnt/β-catenin and the NF-κB signaling pathway during inflammatory responses induced by Haemophilus parasuis in PK-15 and NPTr cells.

  2019cites this paper
• The Role of Ubiquitination in Regulating Embryonic Stem Cell Maintenance and Cancer Development

  2019cites this paper
• Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location

  2019cites this paper
• FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis

  2019cites this paper
• Two major alternative splice variants of beta-TrCP1 interact with CENP-W with different binding preferences

  2018cites this paper
• β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer

  2018cites this paper
• S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer

  2018cites this paper
• Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-κB and β-catenin/TCF signaling pathways

  2018cites this paper
• DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer

  2018cites this paper
• Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

  2018cites this paper
• Xi Qiao: REGULATION OF MYC ACTIVITY BY POST-TRANSLATIONAL MODIFICATIONS

  2018cites this paper
• β‐TrCP upregulates HIF‐1 in prostate cancer cells

  2018cites this paper
• Ubiquitination: Friend and foe in cancer.

  2018cites this paper
• The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor

  2017cites this paper
• Seten: a tool for systematic identification and comparison of processes, phenotypes, and diseases associated with RNA-binding proteins from condition-specific CLIP-seq profiles.

  2017cites this paper
• Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer

  2017cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• Ubiquitination-proteasome system: A new player in the pathogenesis of psoriasis and clinical implications.

  2017cites this paper
• Reciprocal Regulation Between βTrCP and Smurf 1 Suppresses Proliferative Capacity of Liver Cancer Cells † Running title : βTrCP and Smurf 1 are reciprocally regulated

  2017cites this paper
• Reciprocal regulation between βTrCP and Smurf1 suppresses proliferative capacity of liver cancer cells

  2017cites this paper
• The Role of FBXW Subfamily of F-box Proteins in Tumorigenesis

  2017cites this paper
• Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer

  2017cites this paper
• Estrogen and ERα enhanced β‐catenin degradation and suppressed its downstream target genes to block the metastatic function of HA22T hepatocellular carcinoma cells via modulating GSK‐3β and β‐TrCP expression

  2017cites this paper
• Recent advances in SCF ubiquitin ligase complex: Clinical implications.

  2016cites this paper
• A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle

  2016cites this paper
• Involvement of F-BOX proteins in progression and development of human malignancies.

  2016cites this paper
• Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation

  2016cites this paper
• Centromere protein W interacts with beta‐transducin repeat‐containing protein 1 and modulates its subcellular localization

  2016cites this paper
• Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

  2016cites this paper
• Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.

  2016cites this paper
• Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer

  2016cites this paper
• Melatonin, bone regulation and the ubiquitin-proteasome connection: A review.

  2016cites this paper
• MicroRNA regulation of F-box proteins and its role in cancer.

  2016cites this paper
• Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells

  2016cites this paper
• Elucidation, functional clustering and structural characterization of βTrCP1 substrates through a molecular dynamics study.

  2016cites this paper
• FBXO25 promotes cell proliferation, invasion, and migration of NSCLC

  2016cites this paper
• Immunohistochemical detection of Beta Catenin in colon tumors among Sudanese patient

  2015cites this paper
• Dysregulation of ubiquitin ligases in cancer.

  2015cites this paper
• Targeting the ubiquitin pathway for cancer treatment.

  2015cites this paper
• New insights into the mechanism of F-box proteins in colorectal cancer (Review).

  2015cites this paper
• Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis.

  2015cites this paper
• Mathematical modelling suggests a differential impact of β‐transducin repeat‐containing protein paralogues on Wnt/β‐catenin signalling dynamics

  2015cites this paper
• Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and β-catenin signaling molecules.

  2015cites this paper
• 3. roles of fBPs in esophageal cancer 4. roles of fBPs in gastric cancer 5. roles of fBPs in hepatobiliary tumors 6. roles of fBPs in pancreatic cancer 7. roles of fBPs in colorectal cancer

  2014cites this paper
• Roles of F-box proteins in human digestive system tumors (Review).

  2014cites this paper
• Roles of F-box proteins in cancer

  2014cites this paper
• The WD40 Repeat Protein Mutations: Genetics, Molecular Mechanisms and Therapeutic Implications

  2014cites this paper
• IDENTIFICATION OF MOLECULAR MECHANISMS RESPONSIBLE FOR DEGRADATION OF THE TUMOR SUPPRESSOR PROTEIN NUMB IN CANCER.

  2014cites this paper
• Expression of targeted ribozyme against telomerase RNA causes altered expression of several other genes in tumor cells

  2014cites this paper
• The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.

  2014cites this paper
• Circadian gene variants in cancer

  2014cites this paper
• Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.

  2013cites this paper
• SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells

  2013cites this paper
• A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer

  2013cites this paper
• Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.

  2013cites this paper
• Maslinic Acid-Enriched Diet Decreases Intestinal Tumorigenesis in ApcMin/+ Mice through Transcriptomic and Metabolomic Reprogramming

  2013cites this paper
• Phosphorylation, ubiquitylation and characterisation of specific inhibitors of AMPK-related kinase NUAK1/ARK5

  2013cites this paper
• Identification and functional analysis of a novel renal cell carcinoma (RCC) susceptibility gene from an RCC associated constitutional chromosomal translocation.

  2013cites this paper
• NF‐κB and the link between inflammation and cancer

  2012cites this paper